Overview

Study of LJP 394 in Lupus Patients With History of Renal Disease

Status:
Terminated
Trial end date:
2009-02-01
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to determine whether abetimus sodium is more effective than placebo in delaying time to renal flare in SLE patients with a history of renal disease.
Phase:
Phase 3
Details
Lead Sponsor:
La Jolla Pharmaceutical Company
Treatments:
Abetimus